
Last update at 2026-06-08T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Why Is Core Laboratories (CLB) Down 5.9% Since Last Earnings Report?
Fri 23 May 25, 03:30 PMCore Laboratories Down 30% YTD: Should You Hold or Sell the Stock?
Thu 15 May 25, 01:33 PMWhy Core Laboratories Inc. (CLB) is Losing This Week
Wed 30 Apr 25, 08:07 AMCore Laboratories to Post Q1 Earnings: Key Metrics to Watch
Mon 21 Apr 25, 09:37 AMSchlumberger (SLB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Fri 18 Apr 25, 02:00 PMOceaneering International (OII) Surges 13.4%: Is This an Indication of Further Gains?
Thu 10 Apr 25, 12:40 PMLandBridge Co LLC Emerges as a Key Player in Murray Stahl's Latest Investment Moves
Wed 14 Aug 24, 10:02 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 29.95M | 36.11M | -91.17700M | 81.99M | 105.29M |
| Minority interest | -0.20500M | -0.49200M | 0.14M | 0.13M | 80.11M |
| Net income | 19.45M | 19.73M | -97.07300M | 101.98M | 79.53M |
| Selling general administrative | 38.12M | 44.17M | 34.03M | 48.02M | 62.91M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 78.92M | 83.84M | 91.63M | 150.03M | 180.79M |
| Reconciled depreciation | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M |
| Ebit | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M |
| Ebitda | 58.69M | 63.78M | 76.64M | 119.29M | 141.71M |
| Depreciation and amortization | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 41.52M | 45.26M | 55.77M | 96.68M | 118.62M |
| Other operating expenses | 448.21M | 430.58M | 429.67M | 566.21M | 582.96M |
| Interest expense | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M |
| Tax provision | 10.30M | 15.89M | 5.90M | -12.29000M | 25.45M |
| Interest income | 11.57M | 9.15M | 14.37M | 14.69M | 13.33M |
| Net interest income | -11.57000M | -9.15200M | -14.37200M | -14.69000M | -13.32800M |
| Extraordinary items | 0.00000M | 0.00000M | -0.42400M | 7.83M | -0.05800M |
| Non recurring | - | - | 122.20M | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 10.30M | 15.89M | 5.90M | -12.29000M | 25.45M |
| Total revenue | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M |
| Total operating expenses | 37.40M | 44.17M | 34.03M | 48.02M | 62.91M |
| Cost of revenue | 410.82M | 386.41M | 395.63M | 518.18M | 520.05M |
| Total other income expense net | -11.57000M | -9.15200M | -146.95100M | -14.69000M | 0.74M |
| Discontinued operations | - | - | -0.42400M | 7.83M | -0.05800M |
| Net income from continuing ops | 19.66M | 20.22M | -97.07300M | 94.28M | 79.85M |
| Net income applicable to common shares | 19.45M | 19.73M | -97.63700M | 101.98M | 79.53M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 586.39M | 578.35M | 580.85M | 568.58M | 774.67M |
| Intangible assets | 6.93M | 7.48M | 8.14M | 8.58M | 17.45M |
| Earning assets | - | - | - | - | - |
| Other current assets | 13.25M | 28.92M | 29.08M | 30.70M | 28.40M |
| Total liab | 356.59M | 389.40M | 419.85M | 493.01M | 592.53M |
| Total stockholder equity | 224.81M | 188.95M | 161.00M | 75.57M | 182.14M |
| Deferred long term liab | - | 54.69M | 63.44M | 59.73M | 77.82M |
| Other current liab | 32.38M | 39.65M | 40.95M | 49.83M | 50.76M |
| Common stock | 0.47M | 1.19M | 1.19M | 1.15M | 1.15M |
| Capital stock | 0.47M | 1.19M | 1.19M | 1.15M | 1.15M |
| Retained earnings | 120.76M | 85.95M | 68.35M | 50.46M | 160.54M |
| Other liab | - | 75.57M | 91.15M | 87.72M | 109.94M |
| Good will | 99.44M | 99.44M | 99.44M | 99.44M | 213.43M |
| Other assets | 0.00000M | 102.32M | 107.72M | 179.41M | 119.39M |
| Cash | 15.12M | 15.43M | 17.70M | 13.81M | 11.09M |
| Cash and equivalents | - | 15.43M | 17.70M | 13.81M | 11.09M |
| Total current liabilities | 88.10M | 103.14M | 90.78M | 89.75M | 111.59M |
| Current deferred revenue | 4.75M | 5.94M | 7.76M | 5.46M | 13.38M |
| Net debt | 200.26M | 206.96M | 232.56M | 313.17M | 370.69M |
| Short term debt | 10.18M | 11.70M | 12.34M | 11.44M | 11.84M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 215.38M | 222.39M | 250.26M | 326.98M | 381.78M |
| Other stockholder equity | 108.56M | 105.59M | 101.60M | 31.17M | 26.78M |
| Property plant equipment | - | 157.41M | 172.34M | 115.29M | 123.51M |
| Total current assets | 223.14M | 211.70M | 189.06M | 165.85M | 221.24M |
| Long term investments | 4.84M | 4.45M | 4.16M | 4.09M | 3.97M |
| Net tangible assets | - | 115.64M | -58.45800M | 19.59M | 11.65M |
| Short term investments | - | - | - | - | - |
| Net receivables | 123.07M | 106.91M | 96.83M | 83.19M | 131.58M |
| Long term debt | 163.13M | 172.39M | 188.64M | 259.43M | 305.28M |
| Inventory | 71.70M | 60.45M | 45.44M | 38.15M | 50.16M |
| Accounts payable | 33.51M | 45.85M | 29.73M | 23.03M | 35.61M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | 4.70M | 4.55M | 4.06M | 4.28M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -4.97200M | -3.77700M | -10.13300M | -7.20000M | -6.33000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | 1.19M | 1.19M | 1.15M | 1.15M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | 85.95M | 68.35M | 50.46M | 160.54M |
| Treasury stock | - | -1.36200M | -4.07500M | -14.07500M | -29.36400M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 98.58M | -73.02000M | -74.61800M | -76.86900M | -71.28100M |
| Deferred long term asset charges | - | - | - | - | 67.31M |
| Non current assets total | 363.26M | 366.65M | 391.80M | 402.73M | 553.44M |
| Capital lease obligations | 52.25M | 50.00M | 61.63M | 67.55M | 76.50M |
| Long term debt total | - | 172.39M | 188.64M | 259.43M | 305.28M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -3.85600M | -10.22300M | 7.85M | -5.67700M | -70.63900M |
| Change to liabilities | 3.64M | 6.57M | -29.64000M | 1.26M | -17.63700M |
| Total cashflows from investing activities | -3.85600M | -10.22300M | 7.85M | -5.67700M | -70.63900M |
| Net borrowings | -17.20600M | -71.00000M | -47.53600M | 15.00M | 62.24M |
| Total cash from financing activities | -23.37500M | -22.45900M | -63.00500M | -85.87400M | -42.47200M |
| Change to operating activities | -13.63200M | -11.37000M | -21.19100M | 8.65M | -20.92600M |
| Net income | 19.66M | 20.22M | -96.92400M | 93.71M | 79.79M |
| Change in cash | -2.27500M | 3.90M | 2.71M | -2.02400M | -1.28400M |
| Begin period cash flow | 17.70M | 13.81M | 11.09M | 13.12M | 14.40M |
| End period cash flow | 15.43M | 17.70M | 13.81M | 11.09M | 13.12M |
| Total cash from operating activities | 24.96M | 36.58M | 57.87M | 89.53M | 111.83M |
| Issuance of capital stock | 0.00000M | 60.00M | - | - | 0.00000M |
| Depreciation | 17.16M | 18.52M | 20.87M | 22.61M | 23.09M |
| Other cashflows from investing activities | 6.36M | 2.44M | 19.73M | 16.59M | -48.89800M |
| Dividends paid | -1.85300M | -1.83400M | -12.44600M | -97.57400M | 97.25M |
| Change to inventory | -14.86000M | -4.54700M | 1.47M | -3.89200M | -10.40300M |
| Change to account receivables | -10.07800M | -13.52200M | 46.42M | -3.19100M | 2.27M |
| Sale purchase of stock | -3.90300M | -8.25600M | -2.79400M | -3.30000M | -7.45100M |
| Other cashflows from financing activities | 113.38M | 153.63M | -1.76500M | 0.00800M | -1.77000M |
| Change to netincome | 12.71M | 9.84M | -5.82600M | -28.13000M | 34.99M |
| Capital expenditures | 10.22M | 13.54M | 11.88M | 22.27M | 21.74M |
| Change receivables | -10.07800M | -13.52200M | 46.42M | -3.19100M | 2.27M |
| Cash flows other operating | -3.27400M | -0.31600M | 122.07M | -1.24400M | -0.26700M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | -2.27500M | 3.90M | 2.71M | -2.02400M | -1.28400M |
| Change in working capital | -9.56400M | -11.50100M | 35.05M | -10.84000M | -9.89000M |
| Stock based compensation | 7.76M | 19.09M | 7.39M | 20.88M | 34.19M |
| Other non cash items | -10.48800M | -15.76000M | 103.69M | -0.47800M | -17.18500M |
| Free cash flow | 14.74M | 23.04M | 45.99M | 67.26M | 90.09M |
Sector: Energy Industry: Oil & Gas Equipment & Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLB Core Laboratories NV |
0.50 3.87% | 13.43 | 36.22 | 20.62 | 1.76 | 3.63 | 2.07 | 14.62 |
| SLB Schlumberger NV |
1.68 3.06% | 56.55 | 14.01 | 12.05 | 1.70 | 2.86 | 1.94 | 8.58 |
| BKR Baker Hughes Co |
2.25 3.59% | 64.84 | 23.17 | 23.04 | 2.15 | 3.12 | 2.20 | 14.24 |
| HAL Halliburton Company |
1.32 3.37% | 40.50 | 21.08 | 16.16 | 1.44 | 2.93 | 1.65 | 11.22 |
| FTI TechnipFMC PLC |
1.93 2.89% | 68.75 | 30.54 | 24.94 | 2.92 | 8.35 | 2.86 | 15.83 |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
6316 Windfern Road, Houston, TX, United States, 77040
| Name | Title | Year Born |
|---|---|---|
| Mr. Lawrence V. Bruno | Chairman, CEO, Pres & COO | 1960 |
| Mr. Christopher Scott Hill | Sr. VP & CFO | 1970 |
| Ms. Gwendolyn Y. Gresham M.B.A. | Sr. VP of Corp. Devel. & Investor Relations | 1968 |
| Mr. Mark Damian Tattoli | Sr. VP, Sec. & Gen. Counsel | 1972 |
| Mr. Kevin G. Daniels | Chief Accounting Officer, Treasurer & VP | 1964 |
| Mr. Jacobus Schouten | Managing Director | 1955 |
| J. Donald Dumas Jr. | Sr. VP of Production Enhancement & Bus. Devel. | NA |
| Mr. Lawrence V. Bruno | Chairman of the Board, CEO, President & COO | 1959 |
| Mr. Christopher Scott Hill | Senior VP & CFO | 1970 |
| Ms. Gwendolyn Y. Gresham M.B.A. | Senior Vice President of Corporate Development & Investor Relations | 1968 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.